195 related articles for article (PubMed ID: 32323449)
21. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of albuminuria in diabetic nephropathy.
Wada T; Shimizu M; Toyama T; Hara A; Kaneko S; Furuichi K
Clin Exp Nephrol; 2012 Feb; 16(1):96-101. PubMed ID: 21830044
[TBL] [Abstract][Full Text] [Related]
23. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
24. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
25. In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease.
Du S; Zhai L; Ye S; Wang L; Liu M; Tan M
Sci China Life Sci; 2023 Nov; 66(11):2587-2603. PubMed ID: 37405567
[TBL] [Abstract][Full Text] [Related]
26. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
27. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
28. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
29. Urinary exosomes as a novel biomarker for evaluation of α-lipoic acid's protective effect in early diabetic nephropathy.
Sun H; Yao W; Tang Y; Zhuang W; Wu D; Huang S; Sheng H
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28116765
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.
Al-Rubeaan K; Siddiqui K; Al-Ghonaim MA; Youssef AM; Al-Sharqawi AH; AlNaqeb D
Sci Rep; 2017 Jun; 7(1):2684. PubMed ID: 28577020
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
[TBL] [Abstract][Full Text] [Related]
32. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice.
Mohamed R; Ranganathan P; Jayakumar C; Nauta FL; Gansevoort RT; Weintraub NL; Brands M; Ramesh G
J Mol Med (Berl); 2014 Dec; 92(12):1245-56. PubMed ID: 25249008
[TBL] [Abstract][Full Text] [Related]
33. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
Currie G; Delles C
Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
[TBL] [Abstract][Full Text] [Related]
34. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
35. Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy.
Chen J; Zhang Q; Liu D; Liu Z
Metabolism; 2021 Sep; 122():154834. PubMed ID: 34217734
[TBL] [Abstract][Full Text] [Related]
36. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
Kishore L; Kaur N; Singh R
Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
[TBL] [Abstract][Full Text] [Related]
37. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
38. In Diabetic Kidney Disease Urinary Exosomes Better Represent Kidney Specific Protein Alterations Than Whole Urine.
Gudehithlu KP; Garcia-Gomez I; Vernik J; Brecklin C; Kraus M; Cimbaluk DJ; Hart P; Dunea G; Arruda JA; Singh AK
Am J Nephrol; 2015; 42(6):418-24. PubMed ID: 26756605
[TBL] [Abstract][Full Text] [Related]
39. [Novel biomarkers for diabetic nephropathy].
Araki S
Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
[TBL] [Abstract][Full Text] [Related]
40. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
